These innovative therapies , Retatrutide, represent a remarkable advancement in treating metabolic dysfunction and potentially other conditions . They are classified as GLP-1 receptor agonists , https://lilianmfkc764251.blog2freedom.com/41566027/retatrutide-a-thorough-dive-into-metabolic-agents